Merck KGaA (MRK) Stock Chart & Stock Price History → [BUY ALERT] Our #1 A.I. Stock for March (From Behind the Markets) (Ad) Free MRK Stock Alerts €163.60 +3.40 (+2.12%) (As of 03/28/2024 ET) Add Compare Share Share ChartStock AnalysisChartHeadlinesStock AnalysisChartHeadlines Merck KGaA Stock Price Performance5 Day Performance+1.11%1 Month Performance+2.99%3 Month Performance+14.77%6 Month Performance+4.97%Year-To-Date Performance+13.53%1 Year Performance-3.99% Receive MRK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Merck KGaA and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the Markets[BUY ALERT] Our #1 A.I. Stock for MarchIt's the one AI stock nobody is talking about. Cathy Wood just bought 11 million shares of it.Get the name of the stock here - before it takes off >>> MRK Stock Chart for Friday, March, 29, 2024 MRK Chart by TradingView Merck KGaA Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization03/28/2024€159.10€160.20+0.69%€160.45€156.50299,813 shs$20.70 billion03/27/2024€159.60€159.10-0.31%€160.00€158.35255,538 shs$20.56 billion03/26/2024€161.80€159.60-1.36%€161.90€159.50165,432 shs$20.63 billion03/25/2024€161.80€161.80€163.20€160.15209,833 shs$20.91 billion03/22/2024€156.35€161.60+3.36%€161.60€158.65296,731 shs$20.89 billion03/21/2024€157.20€156.35-0.54%€158.00€155.20262,913 shs$20.21 billion Get the Latest News and Ratings for MRK and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Merck KGaA and its competitors with MarketBeat's FREE daily newsletter. 03/20/2024€156.40€157.20+0.51%€157.30€155.70132,706 shs$20.32 billion03/19/2024€156.85€156.40-0.29%€158.20€155.80183,432 shs$20.21 billion03/18/2024€156.85€156.85€160.00€156.85675,862 shs$20.27 billion03/15/2024€160.05€156.85-2.00%€160.00€156.85675,862 shs$20.27 billion03/14/2024€161.25€160.05-0.74%€161.65€159.05190,326 shs$20.68 billion03/13/2024€156.75€161.25+2.87%€161.25€157.50283,053 shs$20.84 billion03/12/2024€157.05€156.75-0.19%€158.75€154.30270,839 shs$20.26 billion03/11/2024€157.05€157.05€159.80€154.75439,134 shs$20.30 billion03/08/2024€158.30€156.60-1.07%€162.05€153.75606,743 shs$20.24 billion03/07/2024€159.05€158.30-0.47%€159.70€157.95455,789 shs$20.46 billion03/06/2024€158.15€159.05+0.57%€160.25€157.30174,826 shs$20.56 billion03/05/2024€158.15€158.15€158.25€156.95148,573 shs$20.44 billion03/04/2024€158.10€158.15+0.03%€158.25€156.95148,573 shs$20.44 billion03/01/2024€158.85€157.80-0.66%€160.10€157.80570,986 shs$20.39 billion02/29/2024€157.85€158.85+0.63%€159.75€157.95251,194 shs$20.53 billion02/28/2024€156.25€157.85+1.02%€157.85€155.80222,863 shs$20.40 billion02/27/2024€159.00€156.25-1.73%€159.40€156.25155,766 shs$20.19 billion02/26/2024€159.00€159.00€159.25€157.35208,442 shs$20.55 billion02/23/2024€153.60€157.10+2.28%€158.05€154.75284,268 shs$20.30 billion02/22/2024€153.40€153.60+0.13%€153.95€149.85263,822 shs$19.85 billion02/21/2024€153.40€153.40€156.25€153.40248,959 shs$19.83 billion02/20/2024€155.75€153.40-1.51%€156.25€153.40248,959 shs$19.83 billion02/19/2024€155.70€155.75+0.03%€156.35€153.75145,953 shs$20.13 billion02/16/2024€154.00€155.45+0.94%€156.45€154.50201,930 shs$20.09 billion02/15/2024€151.35€154.00+1.75%€154.45€150.30246,731 shs$19.90 billion02/14/2024€152.20€151.35-0.56%€153.05€150.65176,983 shs$19.56 billion02/13/2024€152.25€152.20-0.03%€153.55€151.65128,274 shs$19.67 billion02/12/2024€152.25€152.25€153.15€151.35200,353 shs$19.68 billion02/09/2024€149.70€150.85+0.77%€153.15€149.30194,032 shs$19.50 billion02/08/2024€150.05€149.70-0.23%€151.90€149.25201,893 shs$19.35 billion02/07/2024€150.05€150.05€150.40€146.45216,658 shs$19.39 billion02/06/2024€147.30€150.05+1.87%€150.40€146.45216,658 shs$19.39 billion02/05/2024€147.30€147.30€151.05€146.75337,653 shs$19.04 billion02/02/2024€152.40€149.75-1.74%€151.60€149.40237,252 shs$19.35 billion[BUY ALERT] Our #1 A.I. Stock for March (Ad)It's the one AI stock nobody is talking about. Cathy Wood just bought 11 million shares of it.Get the name of the stock here - before it takes off >>>02/01/2024€151.55€152.40+0.56%€154.00€151.15383,918 shs$19.70 billion01/31/2024€153.70€151.55-1.40%€154.45€148.10517,544 shs$19.59 billion01/30/2024€155.90€153.70-1.41%€155.30€153.15360,076 shs$19.86 billion01/29/2024€155.90€155.90€157.15€152.80808,100 shs$20.15 billion01/26/2024€147.10€147.10€147.45€144.90246,712 shs$19.01 billion01/25/2024€148.80€147.10-1.14%€147.45€144.90246,712 shs$19.01 billion01/24/2024€147.95€148.80+0.57%€149.80€148.15323,458 shs$19.23 billion01/23/2024€147.95€147.95€148.20€145.60303,126 shs$19.12 billion01/22/2024€146.20€147.95+1.20%€148.20€145.60303,126 shs$19.12 billion01/19/2024€146.95€146.70-0.17%€147.65€146.25347,704 shs$18.96 billion01/18/2024€146.95€146.95€147.10€143.10445,406 shs$18.99 billion01/17/2024€144.30€146.95+1.84%€147.10€143.10445,406 shs$18.99 billion01/16/2024€145.20€144.30-0.62%€144.70€143.20160,463 shs$18.65 billion01/15/2024€145.20€145.20€145.40€142.20258,970 shs$18.77 billion01/12/2024€142.05€142.05€145.05€141.90322,470 shs$18.36 billion01/11/2024€143.15€142.05-0.77%€145.05€141.90322,470 shs$18.36 billion01/10/2024€141.10€143.15+1.45%€143.70€141.30316,832 shs$18.50 billion01/09/2024€141.10€141.10€143.05€140.50299,366 shs$18.24 billion01/08/2024€142.40€141.10-0.91%€143.05€140.50299,366 shs$18.24 billion01/05/2024€142.40€143.25+0.60%€143.60€141.90191,159 shs$18.51 billion01/04/2024€142.65€142.40-0.18%€143.15€141.30276,198 shs$18.40 billion01/03/2024€144.10€142.65-1.01%€144.85€141.70281,024 shs$18.44 billion01/02/2024€144.10€144.10€144.20€142.30138,577 shs$18.62 billion01/01/2024€144.10€144.10€144.20€142.30138,577 shs$18.62 billion12/29/2023€142.80€142.55-0.18%€143.35€141.35153,004 shs$18.42 billion12/28/2023€141.30€142.80+1.06%€142.85€141.00222,832 shs$18.46 billion Related Companies: Bayer Aktiengesellschaft Stock Chart Carl Zeiss Meditec Stock Chart Fresenius Medical Care Stock Chart Sartorius Aktiengesellschaft Stock Chart Siemens Healthineers Stock Chart Evotec Stock Chart Gerresheimer Stock Chart MorphoSys Stock Chart CompuGroup Medical SE & Co. KGaA Stock Chart Biotest Aktiengesellschaft Stock Chart Receive MRK Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Merck KGaA and its competitors with MarketBeat's FREE daily newsletter. This page (ETR:MRK) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 Media“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyFed launches fourth dollar overhaulStansberry ResearchAI healthcare stock poised for 36,996% growth?Behind the MarketsMost important medical advance in 100 yearsThe Oxford Club Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Merck KGaA Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.